Connection

Robert Haile to Risk Factors

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Risk Factors.
Robert Haile
Connection Strength
1.688
Risk Factors
  1. Folate-genetics and colorectal neoplasia: what we know and need to know next. Mol Nutr Food Res. 2013 Apr; 57(4):607-27.
    View in: PubMed
    Score: 0.051
  2. Genetic variation in insulin pathway genes and distal colorectal adenoma risk. Int J Colorectal Dis. 2012 Dec; 27(12):1587-95.
    View in: PubMed
    Score: 0.049
  3. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila). 2012 Feb; 5(2):328-35.
    View in: PubMed
    Score: 0.047
  4. Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study. Cancer Causes Control. 2011 Apr; 22(4):541-52.
    View in: PubMed
    Score: 0.044
  5. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):525-36.
    View in: PubMed
    Score: 0.041
  6. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):89-100.
    View in: PubMed
    Score: 0.041
  7. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control. 2010 Apr; 21(4):597-608.
    View in: PubMed
    Score: 0.041
  8. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2384-90.
    View in: PubMed
    Score: 0.033
  9. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1863-70.
    View in: PubMed
    Score: 0.033
  10. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2829-39.
    View in: PubMed
    Score: 0.031
  11. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):609-15.
    View in: PubMed
    Score: 0.030
  12. Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas. Pharmacogenetics. 2002 Mar; 12(2):175-9.
    View in: PubMed
    Score: 0.024
  13. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 2021 07; 70(7):1325-1334.
    View in: PubMed
    Score: 0.022
  14. Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2021 05; 30(5):895-903.
    View in: PubMed
    Score: 0.022
  15. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med. 2020 09 03; 18(1):229.
    View in: PubMed
    Score: 0.022
  16. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 09; 29(9):1800-1808.
    View in: PubMed
    Score: 0.021
  17. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer. 2019 11; 121(10):869-876.
    View in: PubMed
    Score: 0.020
  18. Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912259.
    View in: PubMed
    Score: 0.020
  19. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 01; 51(1):76-87.
    View in: PubMed
    Score: 0.019
  20. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260.
    View in: PubMed
    Score: 0.019
  21. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol. 2018 04 01; 47(2):387-388i.
    View in: PubMed
    Score: 0.018
  22. Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations. PLoS One. 2018; 13(2):e0192223.
    View in: PubMed
    Score: 0.018
  23. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
    View in: PubMed
    Score: 0.018
  24. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017 Jul 19; 19(1):83.
    View in: PubMed
    Score: 0.017
  25. Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 06; 108:140-149.
    View in: PubMed
    Score: 0.017
  26. Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int J Cancer. 2017 06 15; 140(12):2728-2733.
    View in: PubMed
    Score: 0.017
  27. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):404-412.
    View in: PubMed
    Score: 0.017
  28. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet. 2016 Oct; 12(10):e1006296.
    View in: PubMed
    Score: 0.017
  29. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.016
  30. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study. Int J Cancer. 2016 Sep 01; 139(5):1081-90.
    View in: PubMed
    Score: 0.016
  31. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016 06; 45(3):940-53.
    View in: PubMed
    Score: 0.016
  32. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer. 2016 Jan 19; 114(2):221-9.
    View in: PubMed
    Score: 0.016
  33. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Fam Cancer. 2015 Dec; 14(4):575-83.
    View in: PubMed
    Score: 0.016
  34. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):68-75.
    View in: PubMed
    Score: 0.015
  35. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Hum Genet. 2015 Nov; 134(11-12):1249-1262.
    View in: PubMed
    Score: 0.015
  36. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53.
    View in: PubMed
    Score: 0.015
  37. Lynch syndrome and cervical cancer. Int J Cancer. 2015 Dec 01; 137(11):2757-61.
    View in: PubMed
    Score: 0.015
  38. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol. 2015 Apr; 44(2):662-72.
    View in: PubMed
    Score: 0.015
  39. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1024-31.
    View in: PubMed
    Score: 0.015
  40. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
    View in: PubMed
    Score: 0.015
  41. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17; 313(11):1133-42.
    View in: PubMed
    Score: 0.015
  42. Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):713-9.
    View in: PubMed
    Score: 0.015
  43. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):512-519.
    View in: PubMed
    Score: 0.015
  44. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis. 2014 Nov; 35(11):2512-9.
    View in: PubMed
    Score: 0.014
  45. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet. 2014 Apr; 10(4):e1004228.
    View in: PubMed
    Score: 0.014
  46. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10.
    View in: PubMed
    Score: 0.014
  47. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May; 146(5):1208-11.e1-5.
    View in: PubMed
    Score: 0.014
  48. Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women. Cancer Epidemiol Biomarkers Prev. 2014 Feb; 23(2):350-5.
    View in: PubMed
    Score: 0.014
  49. Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2094-101.
    View in: PubMed
    Score: 0.013
  50. Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk. PLoS One. 2013; 8(8):e71211.
    View in: PubMed
    Score: 0.013
  51. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 2014 May; 63(5):800-7.
    View in: PubMed
    Score: 0.013
  52. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1547-56.
    View in: PubMed
    Score: 0.013
  53. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control. 2013 Aug; 24(8):1605-14.
    View in: PubMed
    Score: 0.013
  54. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer. 2013 Sep; 49(14):2979-85.
    View in: PubMed
    Score: 0.013
  55. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013 Mar; 34(3):490-7.
    View in: PubMed
    Score: 0.013
  56. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer. 2013 May; 49(7):1578-87.
    View in: PubMed
    Score: 0.013
  57. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36.
    View in: PubMed
    Score: 0.013
  58. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013 Feb 01; 31(4):433-9.
    View in: PubMed
    Score: 0.013
  59. Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiol Biomarkers Prev. 2012 Dec; 21(12):2261-7.
    View in: PubMed
    Score: 0.012
  60. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.012
  61. cis-Expression QTL analysis of established colorectal cancer risk variants in colon tumors and adjacent normal tissue. PLoS One. 2012; 7(2):e30477.
    View in: PubMed
    Score: 0.012
  62. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):681-4.
    View in: PubMed
    Score: 0.012
  63. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
    View in: PubMed
    Score: 0.012
  64. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer. 2012; 64(7):899-910.
    View in: PubMed
    Score: 0.012
  65. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35.
    View in: PubMed
    Score: 0.012
  66. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat. 2012 Jan; 33(1):158-64.
    View in: PubMed
    Score: 0.012
  67. Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women. Cancer Prev Res (Phila). 2011 Dec; 4(12):2035-43.
    View in: PubMed
    Score: 0.012
  68. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat. 2012 Jan; 131(2):571-80.
    View in: PubMed
    Score: 0.012
  69. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer. 2012 Apr 15; 130(8):1898-907.
    View in: PubMed
    Score: 0.012
  70. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012 Feb; 131(2):217-34.
    View in: PubMed
    Score: 0.011
  71. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat. 2011 Nov; 130(2):587-97.
    View in: PubMed
    Score: 0.011
  72. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genet Epidemiol. 2011 Jul; 35(5):389-97.
    View in: PubMed
    Score: 0.011
  73. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):758-66.
    View in: PubMed
    Score: 0.011
  74. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3167-73.
    View in: PubMed
    Score: 0.011
  75. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One. 2010 Jul 16; 5(7):e11636.
    View in: PubMed
    Score: 0.011
  76. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010 Jul 21; 102(14):1012-22.
    View in: PubMed
    Score: 0.011
  77. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis. 2010 Aug; 31(8):1412-6.
    View in: PubMed
    Score: 0.011
  78. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
    View in: PubMed
    Score: 0.011
  79. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 07; 102(7):475-83.
    View in: PubMed
    Score: 0.010
  80. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010 Mar 17; 102(6):391-400.
    View in: PubMed
    Score: 0.010
  81. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.010
  82. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.010
  83. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46.
    View in: PubMed
    Score: 0.010
  84. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
    View in: PubMed
    Score: 0.010
  85. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab. 2010 Feb; 99(2):157-9.
    View in: PubMed
    Score: 0.010
  86. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2745-50.
    View in: PubMed
    Score: 0.010
  87. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev. 2009 Aug; 18(8):2310-7.
    View in: PubMed
    Score: 0.010
  88. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009 Jul 21; 151(2):103-9.
    View in: PubMed
    Score: 0.010
  89. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat. 2010 Feb; 120(1):175-83.
    View in: PubMed
    Score: 0.010
  90. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1041-9.
    View in: PubMed
    Score: 0.010
  91. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15; 169(8):962-8.
    View in: PubMed
    Score: 0.010
  92. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76.
    View in: PubMed
    Score: 0.010
  93. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009 Apr; 136(4):1251-60.
    View in: PubMed
    Score: 0.010
  94. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2625-31.
    View in: PubMed
    Score: 0.009
  95. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15; 68(16):6486-91.
    View in: PubMed
    Score: 0.009
  96. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
    View in: PubMed
    Score: 0.009
  97. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
    View in: PubMed
    Score: 0.009
  98. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 2007 Dec 01; 67(23):11128-32.
    View in: PubMed
    Score: 0.009
  99. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1898-901.
    View in: PubMed
    Score: 0.009
  100. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):906-11.
    View in: PubMed
    Score: 0.009
  101. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1565-7.
    View in: PubMed
    Score: 0.008
  102. Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression. J Gastrointest Surg. 2005 Dec; 9(9):1216-21; discussion 1221.
    View in: PubMed
    Score: 0.008
  103. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41.
    View in: PubMed
    Score: 0.008
  104. A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. Clin Colorectal Cancer. 2005 Mar; 4(6):390-5.
    View in: PubMed
    Score: 0.007
  105. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):622-9.
    View in: PubMed
    Score: 0.006
  106. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):660-3.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.